February 2013

FDA gives warning to CoreValve researcher ()
AF predictor offers simple, effective way to categorize risk in women ()
Medtronic's Engager TAVI gets EU stamp of approval ()
CRT: U.S. gov’t should reinvest some of med device tax into start-ups ()
CRT Video: Jaff speaks to integrating cardio, cerebro care at Mass General ()
Disagreements on Dual Degrees ()
MD/MBAs: Fixing Hearts & Healthcare ()
Paperless Power: Lightening Admin Burden with EHRs ()
CCTA Training Guidelines: Refresh or Retain? ()
EMA cites heart issues in Qsiva’s rejection ()
Individualizing TAVR to Avoid Adverse Events ()
Repair, Replace or Refer? ()
ACC 2.0: Carving Out a Place in the Digital Space ()
Ill Repute: Maintaining Your Good Name in Adversity ()
100 hospitals get 'best' awards from Truven ()
FREEDOM Sets Us Free—for the Sickest Diabetics ()
In-hospital Cardiac Arrest: No Longer ‘Unsalvageable’ ()
CRT: Younger women who undergo PCI at greater risk than younger men ()
Spironolactone results underwhelming, but were the wrong HF patients studied? ()
11% of Riata leads externalized in Danish study ()
CRT: Helicopter parenting ensures quality control for clinical research programs ()
Food for thought: Mediterranean diet cuts CV risk ()
Modified crossover approach may reduce TAVR complications ()
CRT: Inclusion of women in CVD drug trials is better, not so for minorities ()
CRT slides: Data and safety monitoring boards—friend or foe to CV trials? ()
Inappropriate stress echo referrals persist despite AUC, education ()
FDA OK’s Biotronik's single-lead ICD system ()
CRT Q&A: Was appropriate use's makeover enough? ()
CRT Slides: Radial PCI should be default for women ()
CRT: Resolute Integrity DELIVERs strong results for implant, inhospital outcomes ()
CRT: Is a randomized trial needed for PCI CTO? ()
Navigating the Physician Payment Sunshine Act ()
Are you participating in Meaningful Use? ()
ACC releases updated methodology for appropriate use criteria ()
Surviving reform: Imagers must be proactive, involved ()
Standard care beats counseling for cost-effective risk management ()
Heart disease awareness doubles in women; ethnic disparities persist ()
Dayton, Ohio, gets gold star for lowest inhospital mortality ()
A gold standard, made better ()
Medtronic sees single-digit gains in Q3 ()
ICDs: Shared decision-making still elusive ()
Extended use of dabigatran effective for venous thromboembolism ()
EC gives $16M to heart failure consortium ()
Patients with AS+CAD may need earlier AVR intervention ()
Video: Arrhythmia in action ()
N.J. cardiologist admits to taking bribes ()
Perfusion CT helps in predicting stroke outcome ()
EES not inferior to SES for total coronary occlusions ()
AAA stent graft hits U.S. market ()
Hauser: Don’t 'improve' reliable ICD leads ()
Diabetes control: Big gains but far from optimal ()
Merck shells out $688M to settle Vytorin suits ()
FDA grants TAVR IDE to medical societies ()
Million Hearts app targets disease risk factors ()
ACP tests cloud-based diabetes, CVD program ()
Mortality, readmissions & results ()
Most commonly used NSAID carries high cardiovascular risk ()
Ticagrelor may reduce risk of subsequent adverse events ()
MRAs reduce SCD risk in some patients ()
Class 1 recall slapped on St. Jude's occluder delivery system ()
Viewpoint: 3 stages of hospital-physician practice integration ()
Medtronic's updated pacemaker gets approved for MRI use ()
Heart failure, MI mortality, readmission rates not related ()
Bayer submits pulmonary hypertension drug for approval in U.S., EU ()
ACC Corner: Let’s be ’CardioSmart’ ()
CCTA in ED leads to lower costs but more invasive procedures ()
CBO lowers projected SGR costs ()
No relationship between HF medication adherence, Part D spending ()
Too big to fail? Judge accepts WakeMed settlement ()
FDA calls for cardiovascular data for Tresiba ()
HeartWare warns of safety concern with HVAD pump ()
ISC: Embolectomy misses mark, imaging doesn't help outcomes for stroke ()
Contraindications to alteplase may be too strict ()
Merck wins patent fight over Zetia, Vytorin ()
Midei's hospital forks over $5M to DOJ ()
Making dents in steely problems ()
ISC: Maintaining life support in ICH patients may lead to more recoveries ()
ISC: Surgery plus t-PA saves $44K in stroke care costs ()
Endo treatment + t-PA not superior to t-PA alone for ischemic stroke ()
FDA clears new vascular closure system ()
Ramipril improves walking performance in PAD study ()
Endo treatment for ischemic stroke no better than t-PA ()
Long-term rivaroxaban superior to enoxaparin, but adds bleeding risk ()
Slides: Generics to push statin revenues down by $7B ()
Integrating the Healthcare Enterprise Connects IT Systems ()
Edwards sings in solid Q4, FY2012 on strong Sapien sales ()
ICD deactivation: Communication found lacking ()
STS: Late conversions bump up off-pump CABG costs ()
Calcium supplements & men: Good for bones, bad for heart? ()
ABO blood type carries high risk for venous thromboembolism ()
Biodegradable polymer stent shows promise compared with Xience ()
Standards: Stepping up to the plate ()
Medtronic's Evera ICD portfolio scores CE Mark ()
Medicines makes $205M offer for LDL-lowering drug ()
Stress echo is inexpensive, effective way to stratify risk for ACS patients ()
STS: Fewer strokes with PCI but CABG advantage persists ()